Miranda Jayne Toledano insider trades: Entera Bio (ENTX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Miranda reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 22, 2023 | ENTX | ↑ Buy | 23,952 | $0.71 | $17K | Direct | Dec 27, 2023 (5d) |
| Apr 4, 2023 | ENTX | ↑ Buy | 30,000 | $1.01 | $30K | Direct | Apr 6, 2023 (2d) |
| Nov 11, 2022 | ENTX | ↑ Buy | 50,000 | $0.53 | $27K | Direct | Nov 14, 2022 (3d) |
| Jan 14, 2022 | ENTX | ↑ Buy | 6,800 | $2.79 | $19K | Direct | Jan 19, 2022 (5d) |
| Dec 27, 2021 | NXGL | ↑ Buy | 1,819 | $5.49 | $10K | Direct | Jan 3, 2022 (7d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ENTX insiders
Open-market trades in the last 12 months
About Miranda Jayne Toledano's insider trades
Miranda Jayne Toledano is Chief Executive Officer at Entera Bio (ENTX). Since Dec 27, 2021, Miranda has reported 5 open-market purchases worth $103K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (17 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ENTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.